Literature DB >> 7853475

Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity.

B L Fredericksen1, M A Whitt.   

Abstract

We have introduced amino acid substitutions into two regions of the extracellular domain of the vesicular stomatitis virus (VSV) glycoprotein (G protein) and examined the effect of these mutations on protein transport, low-pH-induced stability of G protein oligomers, and membrane fusion activity. We suggested previously that the region between amino acids 118 and 139 may be important for the membrane fusion activity of G protein, on the basis of the characterization of a fusion-defective G protein mutant (M. A. Whitt, P. Zagouras, B. Crise, and J. K. Rose, J. Virol. 64:4907-4913, 1990). It has also been postulated by others that this region as well as the region between amino acids 181 and 212 may constitute putative internal fusion domains of VSV G protein. In this report, we show that three different amino acids substitutions between residues 118 and 139 (G-124-->E, P-127-->D, and A-133-->K) either altered or abolished low-pH-dependent membrane fusion activity. In contrast, substitutions between residues 192 and 212 resulted either in G proteins that had wild-type fusion activity or in mutant proteins in which the mutation prevented transport of G protein to the cell surface. Two of the substitutions between residues 118 and 139 (G-124-->E and P-127-->D) resulted in G proteins that were fusion defective at pH 5.7, although syncytia were observed after cells were treated with fusion buffer at pH 5.5, albeit at levels significantly less than that induced by wild-type G protein. Interestingly, when either G-124-->E or P-127-->D was incorporated into tsO45 virions, the resulting particles were not infectious, presumably because the viral envelope was not able to fuse with the proper intracellular membrane. These results support the hypothesis that the region between amino acids 118 and 139 is important for the membrane fusion activity of VSV G protein and may constitute an internal fusion domain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853475      PMCID: PMC188730     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Activation of influenza A viruses by trypsin treatment.

Authors:  H D Klenk; R Rott; M Orlich; J Blödorn
Journal:  Virology       Date:  1975-12       Impact factor: 3.616

2.  The entry into host cells of Sindbis virus, vesicular stomatitis virus and Sendai virus.

Authors:  D P Fan; B M Sefton
Journal:  Cell       Date:  1978-11       Impact factor: 41.582

3.  A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels.

Authors:  W M Bonner; R A Laskey
Journal:  Eur J Biochem       Date:  1974-07-01

4.  Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.

Authors:  I A Wilson; J J Skehel; D C Wiley
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

5.  The interactionof antiody with the major surface glycoprotein of vesicular stomatitis virus. I. Analysis of neutralizing epitopes with monoclonal antibodies.

Authors:  L Lefrancios; D S Lyles
Journal:  Virology       Date:  1982-08       Impact factor: 3.616

6.  Expression from cloned cDNA of cell-surface secreted forms of the glycoprotein of vesicular stomatitis virus in eucaryotic cells.

Authors:  J K Rose; J E Bergmann
Journal:  Cell       Date:  1982-10       Impact factor: 41.582

7.  Pathway of vesicular stomatitis virus entry leading to infection.

Authors:  K S Matlin; H Reggio; A Helenius; K Simons
Journal:  J Mol Biol       Date:  1982-04-15       Impact factor: 5.469

8.  Hemolysis and cell fusion by rhabdoviruses.

Authors:  K Mifune; M Ohuchi; K Mannen
Journal:  FEBS Lett       Date:  1982-01-25       Impact factor: 4.124

9.  Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein.

Authors:  R Z Florkiewicz; A Smith; J E Bergmann; J K Rose
Journal:  J Cell Biol       Date:  1983-11       Impact factor: 10.539

10.  Cell fusion by Semliki Forest, influenza, and vesicular stomatitis viruses.

Authors:  J White; K Matlin; A Helenius
Journal:  J Cell Biol       Date:  1981-06       Impact factor: 10.539

View more
  52 in total

1.  Mutational evidence for an internal fusion peptide in flavivirus envelope protein E.

Authors:  S L Allison; J Schalich; K Stiasny; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  N-terminal domain of Borna disease virus G (p56) protein is sufficient for virus receptor recognition and cell entry.

Authors:  M Perez; M Watanabe; M A Whitt; J C de la Torre
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation.

Authors:  Y Gaudin; C Tuffereau; P Durrer; A Flamand; R W Ruigrok
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

4.  Enhanced gene transfer with fusogenic liposomes containing vesicular stomatitis virus G glycoprotein.

Authors:  A Abe; A Miyanohara; T Friedmann
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

5.  Mutational analyses of the intergenic dinucleotide and the transcriptional start sequence of vesicular stomatitis virus (VSV) define sequences required for efficient termination and initiation of VSV transcripts.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

6.  Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G.

Authors:  D Odell; E Wanas; J Yan; H P Ghosh
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

7.  Structural intermediates in the fusion-associated transition of vesiculovirus glycoprotein.

Authors:  Eduard Baquero; Aurélie A Albertini; Hélène Raux; Abbas Abou-Hamdan; Elisabetta Boeri-Erba; Malika Ouldali; Linda Buonocore; John K Rose; Jean Lepault; Stéphane Bressanelli; Yves Gaudin
Journal:  EMBO J       Date:  2017-02-10       Impact factor: 11.598

8.  Replication and amplification of novel vesicular stomatitis virus minigenomes encoding viral structural proteins.

Authors:  E A Stillman; J K Rose; M A Whitt
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

9.  The length and sequence composition of vesicular stomatitis virus intergenic regions affect mRNA levels and the site of transcript initiation.

Authors:  E A Stillman; M A Whitt
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

10.  Prediction and identification of a permissive epitope insertion site in the vesicular stomatitis virus glycoprotein.

Authors:  Lisa D Schlehuber; John K Rose
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.